Advertisement

Reactions Weekly

, Volume 1737, Issue 1, pp 10–10 | Cite as

Safety-related label modifications in FDA-approved drugs

Clinical study
  • 35 Downloads

Reference

  1. Shepshelovich D, et al. Postmarketing Safety-Related Modifications of Drugs Approved by the US Food and Drug Administration Between 1999 and 2014 Without Randomized Controlled Trials. Mayo Clinic Proceedings 94: 74-83, No. 1, Jan 2019. Available from: URL: http://doi.org/10.1016/j.mayocp.2018.07.027 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations